Management Of Residual Pituitary Adenoma Patient With Manifestation of Acromegaly and Hyperprolactinemia
Downloads
(1) Lake MG, Krook LS, Cruz S V. 2013. Pituitary Adenomas: An Overview. Am Fam Physician.;88(5):319 27
(2) Phillips N, 2013. the Pituitary MDT. Guidelines for the Management of Pituitary Tumours. Yorkshire: Brain and CNS NSSG; 25 p.
(3) Chanson P, Salenave S. 2004. Diagnosis and Treatment of Pituitary Adenomas. Minierva endocrinologica; 29(4):241-75
(4) Laws ER & Lanzino G, Elsevier Laws ER, Ezzat S, Asa, SL, Rio LM, Michael L, Knutzen R 2014. Pituitary Disorders – Diagnosis and Management Transsphenoidal surgery. Editors (eds.): Wiley-Blackwell; London, 357pp
(5) Dallapiazza RF, Grober Y, Starke RM, Laws ER Jr, Jane JA Jr. 2015. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery; 76(1): 42-53
(6) Arafah B M, Nasrallah M P. 2011. Pituitary tumors: pathophysiology, clinical, manifestations and management. Endocrine-related Cancer; 287-305.
(7) Freda PU & Wardlaw SL 2010. diagnosis and treatment of pituitary tumors. Journal of Clinical Endocrinology and Metabolism. Clinical review 110; 843859–3866
(8) Chanson P, Raverot G, Cortet rudelli C, Salenave S. Management of clinically non functioning pituitary adenoma. Annals of Endrocrinology. 2015;76:239 47
(9) Olsson DS. 2014. Non functioning pituitary tumours mortality , morbidity and tumour progression. Institute of Medicine at the Sahlgrenska Academy University of Gothenburg
(10) Bergsneider,.2011.Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab.;96(7):1992–2003
(11) Laws, ER, Ezzat, S. Asa, S.L., Rio, L.M., Michel, L, Wiley-Blackwell Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML Knutzen, R. (2013). Pituitary Disorders – Diagnosis and Management. Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg;;114:68 (Suppl 1); 144-150
(12) Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, Wass JAH. Acromegaly: An Endocrine Society Clinical Practice Guideline.
(13) Ajmal A, Joffe H, Nacthtigall LB,.Psycotropic-indiced hyperprolactinemia aclinical review psychosomatics.2014; 55-29
(14) Iuliano, S.L. & Laws, E.R. (2013). Recognizing the clinical manifestations of acromegaly: case studies. Journal of the A merican Association of Nurse Practitioners; 26 (3): 136-142
(15) Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J. Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab. 2009;23(5):555–574.
(16) Melmed S. 2009. Acromegaly pathogenesis and treatment. J Clin invest;.p( 3)189-202.
(17) Mesfro A, Webb SM, Astorga R, Benito P, Calala M, Gastambide S.2004. Epidemiology, clinical characteristics, outcome, morbidity and modality in acromegaly based on the Spanish acromegaly registry. Eur J Endocrinol;151:439-46
(18) Akin F, Yerlikaya E. 2011. Acromegaly and Gigantism. Pamukkale University Faculty of Medicine Division of Endocrinology and Metabolism, Turkey: 53-74
(19) Molitch ME, Clemmons DL, Malozowski S, Merriam GR, Shalet SM, Vance ML. 2006. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline Journal Clinical Endocrinol Metab; 91(5):1621-34
(20) Calao A, Auremma RS , Galdiero M, Lombardi Q, Pivonello R. 2009. Effect of initial therapy for five years with somatostatin analoqs for acromegaly on Growth hormone and insulin like growth factor 1 level, tumor shrinkle, cardiovascular disease: aprospective study. J Clin Endocrine Metab; 94(10): 3746-56
(21) Neggers SJ, de Herder WW, Feelders RA, van der Lely AJ.Convention of daily pegvisomant to weekly pegvisomant combined with long acting somatostatin analogs in controlled acromegaly patients. Pituitary. 2011;14;2:p 53-258
(22) Bergsneider, Marvin ,Neil Martin, Anthony Heaney, Won Kim, Marilene Wang, Jeffrey Suh ,Nader Pouratian, Tania Kaprealian dkk, et.al 2016. Pituitary Tumor Program. L.A. Available in http://pituitary.ucla.edu/, http://pituitary.ucla.edu/pituitary-adenomas accessed 2 Desember 2016.
(23) Vincent M Frederick, Talavera Francisco, Egan Robert, Baker J Matthew, Lorenzo Nicholas. 2007. Pituitary tumors. eMedicine Neurology Neurooncology Journal of Clinical Endocrinology and Metabolism; 99(11):3933-51
(24) Sherlock M, Ayuk J, Tomlinson JW, et al.2010. Mortality in patients with pituitary disease. Endocr Rev; 31(3):301–34
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).